Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Long-term Study to Evaluate Growth and Development Outcomes in Patients With Infantile-Onset Pompe Disease Who Are Receiving Alglucosidase Alfa

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00486889
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:00.548763+00:00
Published At
2022-08-26T00:00:00+00:00
Record Updated At
2022-08-26
Results Posted At
2022-08-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pompe Disease", "Glycogen Storage Disease Type II (GSD-II)", "Acid Maltase Deficiency Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-08-26"
protocolSection.identificationModule.nctId
"NCT00486889"
protocolSection.identificationModule.officialTitle
"A Long-term Study to Evaluate Growth and Development Outcomes in Patients With Infantile-Onset Pompe Disease Who Are Receiving Alglucosidase Alfa"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2022-08-26"

Study condition terms

  • Pompe Disease (protocolSection.conditionsModule.conditions)
  • Glycogen Storage Disease Type II (GSD-II) (protocolSection.conditionsModule.conditions)
  • Acid Maltase Deficiency Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.